Relmada Therapeutics, Inc. (RLMD)

3.745 -0.06 (-1.45%) USD  |  NASDAQ  |  Jan 16, 16:00
3.745 0.00 (0.00%) After-Hours: 20:00
More

Relmada Therapeutics EBIT (TTM)

EBIT (TTM) Chart

View EBIT (TTM) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (TTM) Range, Past 5 Years

View EBIT (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (TTM) Benchmarks

View EBIT (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade